|Pre-announcement price 2||$1.66||55.40%|
|52-week low 3||$0.77||233.10%|
We're concerned that, if the Crestview Transaction is not approved, Accuride's share price could decline substantially from pre-announcement levels. PROTECT THE VALUE OF YOUR INVESTMENT BY VOTING "FOR" THE CRESTVIEW TRANSACTION TODAY!THE CRESTVIEW TRANSACTION IS THE BEST OPTION AVAILABLE TO MAXIMIZE SHAREHOLDER VALUE For over a year, Accuride's Board conducted a thorough strategic review process during which it thoughtfully considered strategic alternatives available to Accuride. This process culminated in Crestview's $2.58 per share all cash offer. The Company then undertook an extensive 35 day "go shop" process to solicit alternative proposals from strategic parties and financial sponsors. The Company did not receive any alternative proposal to Crestview's $2.58 all-cash offer. Your Board, ISS, and Glass Lewis all agree that Accuride shareholders should vote to approve the Crestview transaction. You will not be receiving any proxy card from Coliseum. Don't wait - vote "FOR" the Crestview transaction on the enclosed proxy card today. Sincerely, John W. Risner Chairman & Richard F. Dauch President and Chief Executive Officer If you have questions or need assistance voting your shares please contact: Georgeson LLC1290 Avenue of the Americas, 9th FloorNew York, NY 10104 Shareholders call toll-free: (800) 676-0281 About Accuride Corporation With headquarters in Evansville, Ind., USA, Accuride Corporation is a leading supplier of components to the North American and European commercial vehicle industries. The Company's products include commercial vehicle wheels and wheel-end components and assemblies. The company's products are marketed under its brand names, which include Accuride®, Accuride Wheel End Solutions™, Gunite® and Gianetti Ruote™. Accuride's common stock trades on the New York Stock Exchange under the ticker symbol ACW. For more information: www.AccurideCorp.com. Additional Information About the Acquisition and Where to Find It In connection with the proposed merger contemplated by the Agreement and Plan of Merger, dated September 2, 2016, by and among Accuride, Armor Parent Corp. and Armor Merger Sub Corp. (such transaction, the "proposed transaction" and such agreement, the "Merger Agreement"), on October 17, 2016, Accuride filed with the Securities and Exchange Commission (the "SEC") and sent to its stockholders a definitive proxy statement. INVESTORS OF ACCURIDE ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND OTHER RELEVANT MATERIALS CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT ACCURIDE, ARMOR PARENT CORP., ARMOR MERGER SUB CORP. AND THE PROPOSED TRANSACTION. Investors may obtain a free copy of these materials and other documents filed by Accuride with the SEC at the SEC's website at www.sec.gov, at Accuride's website at www.accuridecorp.com or by sending a written request to Accuride at 7140 Office Circle, Evansville, Indiana 47715, Attention: General Counsel and Corporate Secretary. Participants in the Solicitation Accuride and its directors, executive officers and certain other members of management and employees may be deemed to be participants in soliciting proxies from its stockholders in connection with the proposed transaction. Information regarding the persons who may, under the rules of the SEC, be considered to be participants in the solicitation of Accuride's stockholders in connection with the proposed transaction, as well as any direct or indirect interests such persons may have in the proposed transaction, is set forth in the definitive proxy statement for Accuride's 2016 Annual Meeting of Stockholders and the definitive proxy statement filed in connection with the proposed transaction.
Forward-Looking StatementsCertain statements contained in this document may be considered forward-looking statements within the meaning of the U.S. securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the proposed transaction and the ability to consummate the proposed transaction. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "believes," "plans," "anticipates," "projects," "estimates," "expects," "intends," "strategy," "future," "opportunity," "may," "will," "should," "could," "potential" or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: (1) Accuride may be unable to obtain shareholder approval for the proposed transaction; (2) the conditions to the closing of the proposed transaction may not be satisfied and required regulatory approvals may not be obtained; (3) the proposed transaction may involve unexpected costs, liabilities or delays; (4) the business of Accuride may suffer as a result of uncertainty surrounding the proposed transaction; (5) the outcome of any legal proceedings related to the proposed transaction; (6) Accuride may be adversely affected by other economic, business, legislative, regulatory and/or competitive factors; (7) the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; (8) risks that the proposed transaction disrupts current plans and operations and the potential difficulties in employee retention as a result of the proposed transaction; (9) the failure by Armor Parent Corp. or Armor Merger Sub Corp. to obtain the necessary debt and equity financing arrangements set forth in the commitment letters received in connection with the proposed transaction; and (10) other risks to consummation of the proposed transaction, including the risk that the proposed transaction will not be consummated within the expected time period or at all. If the proposed transaction is consummated, Accuride's shareholders will cease to have any equity interest in Accuride and will have no right to participate in its earnings and future growth. The foregoing review of important factors that could cause actual results to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including the Accuride's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2015, the definitive proxy statement for its 2016 Annual Meeting of Stockholders, the definitive proxy statement filed in connection with the proposed transaction and recent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the SEC, which are available on the SEC's website at www.sec.gov . Except as required by applicable law, Accuride undertakes no obligation to update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Accuride does not intend, and assumes no obligation, to update any forward-looking statements. Accuride's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2015, the definitive proxy statement for its 2016 Annual Meeting of Stockholders, the definitive proxy statement filed in connection with the proposed transaction and recent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the SEC, are available on the SEC's website at www.sec.gov . 1 Permission to use quotes neither sought nor obtained. 2 Premium to day prior to announcement on September 1, 2016. 3 February 2, 2016.